| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
1e-07 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0006 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.004 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |